I agree - have held CMPX since 1996. It has taken a long time for things to work out - but it is now. The Jerry Rice usage of the product (now that it is available in the U.S. without a prescription) should increase unit volume among H.S. and college athletes. If CMPX can earn $0.60 on an annual basis, the equity should be able to carry a 15 P/E or $9 per share.